Issue 2019/03
September, 2019
DiaSys getting fit for future
Being a company in the health care sector, it is of utmost priority for DiaSys to offer a dedicated internal health care program, at least for headquarter staff, to encourage employees to stay fit by participating in many local sports activities.

Find out more
New DiaSys partner in Tunisia
We are happy to welcome our new partner in Tunisia, Agora Médicale, based in Tunis.

Find out more
100 per cent respons®
Hospic Sarl, long-term partner in Algeria, has recently achieved the 100th installation of respons®920! We have always been convinced to achieve brilliant success when we started cooperating nine years ago. We warmly thank Hospic as well as their team and wish them all the best for the future in Algeria.
 Introducing DiaSys Total bile acids 21 FS
Bile acids are amphipathic sterols synthesized from cholesterol in the liver and secreted into the intestine where they play an essential role in emulsifying dietary lipids.

Find out more
 New – Mini cup adapter for respons®910
DiaSys is actually introducing a mini cup adapter for respons®910 (Cat. No. 960647). By means of this special adapter, the sample dead volume may decrease from 50 µL to 10 - 15 µL, which is useful for applications with a small specimen volume (e.g. in pediatrics, veterinary medicine, etc.).

Find out more
 Lactate: Supporting diagnosis and sepsis management
Sepsis is a leading cause of acute hospital mortality and commonly results in multi-organ dysfunction. Hyperlactatemia is very common in patients with sepsis and septic shock and is closely associated with poor prognosis.

Find out more
 Superiority of DiaSys Lp-PLA2 confirmed by Chinese study
Cardiovascular disease (CVD) has become the most common cause of death in both developed and developing countries worldwide and represents a large economic burden. Although several biomarkers for predicting cardiovascular disease exist, CVD is far from being accurately diagnosed and assessed. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a vascular inflammatory factor that has been demonstrated to be positively correlated with CVD and ischemic stroke.

Find out more
 Statins increase Lp(a) value
According to several studies, elevated lipoprotein (a) [Lp(a)] levels are considered a risk factor for cardiovascular diseases. A recent meta-analysis published in Lancet has shown that elevated Lp(a) levels in patients before and during statin therapy are associated with an increased cardiovascular risk; the association is also present when patients exhibit LDL-C levels below 50 mg/dL and/or are at medication for statins or PCSK9 inhibitors.

Find out more
 European REACH regulation bans tritons and its derivates
REACH stands for “Registration, Evaluation, Authorization and Restriction of Chemicals“. It was issued in 2007 to further protect human health and the environment from all hazards arising from chemicals. To comply with REACH, all risks posed by chemicals manufactured and marketed in the EU must be identified and controlled. If such risks are not controlled, the authorities may restrict the use of chemicals.

Find out more
 Promotional tools
Two new roll-up motives have lately been developed – open data for your own promotion has been uploaded to the promotional toolbox on DiaSys’ website – do not forget to ask for your personal password.

Find out more





Münzlauf 2019 – DiaSys was part of it
On Friday, June 28, 2019, “Münzlauf” took place in Koblenz for the 17th time with a record participation number of 15.000 finishers.

Find out more
DiaSys Diagnostic Systems present in Kharkiv, Ukraine
The first Society for Clinical Laboratory Diagnostics in Ukraine was established within the existing Medical Society in 1861 in Kharkiv on the initiative of Professor Wilhelm F. Grube. Therefore, organizing events for the Kharkiv Society for Clinical Laboratory Diagnostics has a long history and is most important for this direction in Eastern Ukraine.

Find out more
23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, Barcelona
DiaSys representatives participated in EuroMedLab Barcelona 2019. This 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine took place from 19th to 23rd of May in the International Convention Centre (CCIB) in Barcelona.

 Find out more
71st AACC in Anaheim, August 2019
As in the year before, the Annual Scientific Meeting & Clinical Lab Expo in Anaheim was a great success for DiaSys Diagnostic Systems GmbH. We promoted our products to existing distributors as well as to potential prospects.

Find out more
Meet DiaSys in India and Germany
We are pleased to announce our participation at the 15th APFCB congress which will be in Jaipur from November 17 through 20, 2019 and our participation in the world's largest medical exhibition MEDICA, taking place almost at the same time from November 18 through 21, 2019 in Düsseldorf.

Find out more
If you have any questions or suggestions please contact:

Executive board:
Dr. Günther Gorka,
Dr. Jan Gorka,
Peter Zöller
DiaSys Diagnostic Systems GmbH
Alte Strasse 9 | 65558 Holzheim | DE

Fon: +49 (0) 64 32 - 91 46-0
Fax: +49 (0) 64 32 - 91 46-32
Register court: AG Montabaur
Registration number: HRB 7106

Sales tax identification number according to
§ 27 a VAT registration number: DE 148-404-658